Sanofi (STU:SNW) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


STU:SNW Sanofi SA STU:SNW
87 GF Score
Price €73.45
GF Value €106.81
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Sanofi Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sanofi's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

STU:SNW vs LLY, JNJ, ABBV: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - General subindustry, Sanofi's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Sanofi's Margin of Safety % (DCF Earnings Based) falls into.


STU:SNW
87GF Score
Sanofi SA STU:SNW
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (STU:SNW) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €73.45 is trading 31.2% below its estimated GF Value™ of €106.81. GuruFocus considers Sanofi to be Possible Value Trap.

Key valuation signals for STU:SNW:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €106.81 vs. price of €73.45 (31.2% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the STU:SNW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
87GF Score

Get the complete analysis for STU:SNW

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€73.45
Price
€106.81
GF Value